Anemia and 9-year domain-specific cognitive decline in community-dwelling older women: The Women's Health and Aging Study II.
OBJECTIVE
To test the hypothesis that anemia (hemoglobin <12 g/dL) is associated with a faster rate of cognitive decline over 9 years in a community-dwelling sample of women aged 70 to 80 at baseline.


METHODS
A population-based, prospective cohort study.


METHODS
East Baltimore, Maryland.


METHODS
Four hundred thirty-six women sampled to be representative of the two-thirds least-disabled women aged 70 to 80 at baseline (1994-1996).


METHODS
Nine-year trajectories of cognitive decline, analyzed using linear random effects models, in the domains of immediate verbal recall, delayed verbal recall, psychomotor speed, and executive function.


RESULTS
At baseline and after adjustment for demographic and disease covariates, women with anemia were slower to complete a test of executive function; the difference in baseline function between women with anemia and those without was -0.43 standard deviations (SDs) (95% confidence interval (CI)=-0.74 to -0.13) on the Trail Making Test Part B. During follow-up, anemia was associated with a faster rate of decline in memory. Between baseline and Year 3, the difference in the rates of decline between women with anemia and those without was -0.18 SDs per year (95% CI=-0.29 to -0.06) on the Hopkins Verbal Learning Test (HVLT) and -0.15 SDs per year (95% CI=-0.26 to -0.04) on the HVLT-Delayed.


CONCLUSIONS
Anemia was associated with poorer baseline performance on a test of executive function and with faster rates of decline on tests of immediate and delayed verbal recall. If this relationship is causal, it is possible that treatment of anemia could prevent or postpone cognitive decline.
Deal
Jennifer A
JA
Department of Epidemiology, Center on Aging and Health, The Johns Hopkin Medical Institutions, 2024 E. Monument St, Suite 2-700, Baltimore, MD 21205, USA. jdeal@jhsph.edu
Carlson
Michelle C
MC
Xue
Qian-Li
QL
Fried
Linda P
LP
Chaves
Paulo H M
PH
D000368:Aged; D000544:Alzheimer Disease / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D000740:Anemia / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D015142:Baltimore; D003072:Cognition Disorders / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D015331:Cohort Studies; D015897:Comorbidity; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006452:Hemoglobinometry; D006801:Humans; D008570:Memory, Short-Term / Q000502:physiology; D009483:Neuropsychological Tests / Q000706:statistics & numerical data; D011446:Prospective Studies; D011594:Psychometrics; D011597:Psychomotor Performance / Q000502:physiology; D011930:Reaction Time / Q000502:physiology; D012153:Retention, Psychology / Q000502:physiology; D012307:Risk Factors
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
J Am Geriatr Soc. 2007 Oct;55(10):1557-65
17697104
Neurology. 2004 Dec 28;63(12):2341-7
15623697
Am J Med. 2005 May;118(5):496-502
15866252
J Gerontol A Biol Sci Med Sci. 2007 Oct;62(10):1134-41
17921427
Z Gerontol. 1993 May-Jun;26(3):129-37
8337905
Psychol Rev. 1996 Jul;103(3):403-28
8759042
J Psychiatr Res. 1982-1983;17(1):37-49
7183759
Psychol Aging. 2002 Jun;17(2):179-93
12061405
Neurobiol Aging. 2006 Feb;27(2):278-84
15893409
Blood Rev. 2006 Jul;20(4):213-26
16472893
Neuropsychology. 2005 Jul;19(4):520-31
16060827
J Am Geriatr Soc. 2006 Sep;54(9):1429-35
16970654
Blood. 2004 Oct 15;104(8):2263-8
15238427
Kidney Int. 1990 Sep;38(3):480-6
2232491
Crit Rev Oncol Hematol. 2006 Feb;57(2):175-82
16213740
Nephron. 1976;16(1):31-41
1244564
Am J Med. 2006 Apr;119(4):327-34
16564775
Blood. 2007 Jun 1;109(11):4663-70
17284526
Psychol Aging. 1995 Mar;10(1):123-39
7779310
J Am Geriatr Soc. 2002 Jul;50(7):1257-64
12133021
J Gerontol B Psychol Sci Soc Sci. 1999 Sep;54(5):S262-70
10542828
Ann Epidemiol. 1997 Apr;7(3):219-24
9141646